April 03, 2020
McKesson Corp. has sought another dismissal of a shareholder derivative action accusing the company of concealing its involvement in alleged pharmaceutical industry price-fixing, telling a California federal judge that the latest complaint didn't properly address the issues in the old one.
January 21, 2020
A California federal judge said Tuesday that the executives and directors of pharmaceutical wholesaler McKesson won't have to face a shareholder's derivative class action alleging they shirked their responsibilities by letting the company get involved in price-fixing.
August 06, 2019
McKesson Corp. and its executives asked a California federal court to toss a derivative action accusing the drug distributor's board of failing to prevent the company's alleged involvement in an industrywide conspiracy to drive up generic-drug prices, claiming that the plaintiff didn't show that the board lacked independence.
May 24, 2019
A McKesson Corp. shareholder claims the drug distributor's directors benefited from a "massive insider trading binge" while participating in an industrywide conspiracy to drive up the prices of generic drugs, in a suit removed to California federal court Thursday.